Fund for patients with asbestos induced diseases may run out

doi:10.1136/bmj.328.7442.728-c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Bob Burton

Canberra

Documents tabled at an inquiry into a compensation fund for people with diseases induced by asbestos have shown that only months after the fund was established by an asbestos manufacturer the fund's chairman feared that it had a massive shortfall.

In February 2001 James Hardie Industries established a non-profit trust, the Medical Research and Compensation Foundation, with $A293m (£120m; $220m; €180m) of assets to cover the company's liabilities for asbestos induced diseases. Eight months after the company established the foundation it moved its head office to the Netherlands.

At the first hearing of the inquiry initiated …